1. Home
  2. DCTH vs HONE Comparison

DCTH vs HONE Comparison

Compare DCTH & HONE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCTH
  • HONE
  • Stock Information
  • Founded
  • DCTH 1988
  • HONE 1917
  • Country
  • DCTH United States
  • HONE United States
  • Employees
  • DCTH N/A
  • HONE N/A
  • Industry
  • DCTH Medical/Dental Instruments
  • HONE Major Banks
  • Sector
  • DCTH Health Care
  • HONE Finance
  • Exchange
  • DCTH Nasdaq
  • HONE Nasdaq
  • Market Cap
  • DCTH 518.0M
  • HONE 525.1M
  • IPO Year
  • DCTH N/A
  • HONE 2016
  • Fundamental
  • Price
  • DCTH $14.88
  • HONE $11.46
  • Analyst Decision
  • DCTH Strong Buy
  • HONE Hold
  • Analyst Count
  • DCTH 4
  • HONE 1
  • Target Price
  • DCTH $22.25
  • HONE $13.00
  • AVG Volume (30 Days)
  • DCTH 356.0K
  • HONE 248.1K
  • Earning Date
  • DCTH 03-06-2025
  • HONE 01-30-2025
  • Dividend Yield
  • DCTH N/A
  • HONE 2.79%
  • EPS Growth
  • DCTH N/A
  • HONE 78.38
  • EPS
  • DCTH N/A
  • HONE 0.66
  • Revenue
  • DCTH $22,644,000.00
  • HONE $164,292,000.00
  • Revenue This Year
  • DCTH $1,672.40
  • HONE N/A
  • Revenue Next Year
  • DCTH $116.33
  • HONE $10.47
  • P/E Ratio
  • DCTH N/A
  • HONE $17.36
  • Revenue Growth
  • DCTH 945.91
  • HONE 0.52
  • 52 Week Low
  • DCTH $3.70
  • HONE $9.16
  • 52 Week High
  • DCTH $16.97
  • HONE $14.00
  • Technical
  • Relative Strength Index (RSI)
  • DCTH 46.47
  • HONE 42.54
  • Support Level
  • DCTH $15.50
  • HONE $11.91
  • Resistance Level
  • DCTH $16.43
  • HONE $12.30
  • Average True Range (ATR)
  • DCTH 0.72
  • HONE 0.48
  • MACD
  • DCTH -0.25
  • HONE -0.03
  • Stochastic Oscillator
  • DCTH 2.79
  • HONE 49.66

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.

About HONE HarborOne Bancorp Inc.

HarborOne Bancorp Inc is a bank holding company. The company is engaged in providing financial services like accepting deposits, lending loans, online and mobile banking, cash management, credit cards, money market accounts, and wealth management. The Company has two reportable segments: HarborOne Bank and HarborOne Mortgage. The bank provides financial services to individuals and businesses online and through its full-service branches located in Massachusetts and Rhode Island, one limited-service branch, and a commercial lending office in each of Boston, Massachusetts and Providence, Rhode Island.

Share on Social Networks: